Free Access
Issue
Med Sci (Paris)
Volume 21, Number 4, Avril 2005
Page(s) 405 - 411
Section M/S revues
DOI https://doi.org/10.1051/medsci/2005214405
Published online 15 April 2005
  1. Wollfe AP, Matzke MA. Epigenetics : regulation through repression. Science 1999; 286 : 481–6. [Google Scholar]
  2. Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat Genet 2002; 3 : 662–73. [Google Scholar]
  3. Egger G, Liang G, Aparicio A, et al. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004; 429 : 457–63. [Google Scholar]
  4. Lund AH, van Lohuizen M. Epigenetics and cancer. Genes Dev 2004; 18 : 2315–35. [Google Scholar]
  5. Jones PA, Baylin SB. The fundamental roles of epigenetic events in cancer. Nat Rev Genet 2002; 3 : 415–28. [Google Scholar]
  6. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349 : 2042–54. [Google Scholar]
  7. Hake SB, Xiao A, Allis CD. Linking the epigenetic language of covalent histone modifications to cancer. Br J Cancer 2004; 90 : 761–9. [Google Scholar]
  8. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004; 4 : 143–53. [Google Scholar]
  9. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002; 16 : 6–21. [Google Scholar]
  10. Bestor TH. The DNA methyltransferases of mammals. Hum Mol Genet 2000; 9 : 2395–402. [Google Scholar]
  11. Fuks F. Les méthyltransférases de l’ADN : du remodelage de la chromatine au cancer. Med Sci (Paris) 2003; 19 : 477–80. [Google Scholar]
  12. Ting AH, Jair KW, Suzuki H, et al. CpG island hypermethylation is maintained in human colorectal cancer cells after RNAi-mediated depletion of DNMT1. Nat Genet 2004; 36 : 582–4. [Google Scholar]
  13. Rhee I, Bachman KE, Park BH, et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 2002; 416 : 552–6. [Google Scholar]
  14. Claus R, Lübbert M. Epigenetic target in hematopietic malignancies. Oncogene 2003; 22 : 6489–96. [Google Scholar]
  15. Filion G, Defossez PA. Les protéines se liant à l’ADN méthylé : interprètes du code épigénétique. Med Sci (Paris) 2004; 20 : 7–8. [Google Scholar]
  16. Xu GL, Bestor TH, Bourc’his D, et al. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 1999; 402 : 187–91. [Google Scholar]
  17. Kriaucionis S, Bird A. DNA methylation and Rett syndrome. Hum Mol Genet 2003; 12 : 221–7. [Google Scholar]
  18. Chen WY, Zeng X, Carter MG, et al. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nat Genet 2003; 33 : 197–202. [Google Scholar]
  19. Jenuwein T, Allis CD. Translating the histone code. Science 2001; 293 : 1074–80. [Google Scholar]
  20. Kouzarides T. Histone methylation in transcriptional control. Curr Opin Genet Dev 2002; 12 : 198–209. [Google Scholar]
  21. Iyer NG, Ozdag H, Caldas C. p300/CBP and cancer. Oncogene 2004; 23 : 4225–31. [Google Scholar]
  22. Schneider R, Bannister A, Kouzarides T. Unsafe SETs : histone lysine methyltransferases and cancer. Trends Biochem Sci 2002; 27 : 396–402. [Google Scholar]
  23. Cao R, Zhang Y. The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Curr Opin Genet Dev 2004; 14 : 155–64. [Google Scholar]
  24. Roberts CWM, Orkin SH. The SWI/SNF complex-chromatin and cancer. Nat Rev Cancer 2004; 4 : 133–42. [Google Scholar]
  25. Fujita N, Jaye DL, Kajita M, et al. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 2003; 113 : 207–19. [Google Scholar]
  26. Fahrner JA, Baylin, SB. Heterochromatin : stable and unstable invasions at home and abroad. Genes Dev 2003; 17 : 1805–12. [Google Scholar]
  27. Villar-Garea A, Esteller M. DNA demethylating agents and chromatin-remodelling drugs : which, how and why. Curr Drug Metab 2003; 4 : 11–31. [Google Scholar]
  28. Bachman KE, Park BH, Rhee I, et al. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell 2003; 3 : 89–95. [Google Scholar]
  29. Gius D, Cui H, Bradbury CM, et al. Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. Cancer Cell 2004; 6 : 361–71. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.